3 employees
BioVascular develops and commercializes drugs and devices for the control of for platelet mediated cardiovascular diseases.
2006
$11M
from 2 investors over 2 rounds
BioVascular Inc raised $11M on February 7, 2008
Investors: Domain Associates and Merck Group